Hatfield company launches epilepsy drug

A NEW drug for people with epilepsy was launched this week by a company based in Hatfield.

Japanese drug firm Eisai, which has its UK head office in Mosquito Way, has announced the launch of Zebinix, a novel, once-daily drug for adults who suffer from partial-onset seizures – the most common type of epilepsy.

Patients using Zebinix have reported better seizure control, health-related quality of life and a reduction in depressive feelings, which can be a symptom of poorly controlled epilepsy.

Eisai UK managing director Nick Burgin said: “The effective treatment of patients with partial-onset seizures remains a major challenge for clinicians as well as patients and their families.

“We are delighted to be bringing patients such a promising new treatment.”

You may also want to watch:

Become a Supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Become a Supporter